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Abstract. 
 
The regulation of cadherin-mediated adhe-
sion at the cell surface underlies several morphogenetic 
processes. To investigate the role of cadherin regula-
tion in morphogenesis and to begin to analyze the mo-
lecular mechanisms of cadherin regulation, we have 
screened for monoclonal antibodies (mAbs) that allow 
us to manipulate the adhesive state of the cadherin 
molecule.
 
Xenopus
 
 C-cadherin is regulated during convergent 
extension movements of gastrulation. Treatment of ani-
mal pole tissue explants (animal caps) with the meso-
derm-inducing factor activin induces tissue elongation 
and decreases the strength of C-cadherinÐmediated ad-
hesion between blastomeres (Brieher, W.M., and B.M. 
Gumbiner. 1994. 
 
J. Cell Biol.
 
 126:519Ð527). We have 
generated a mAb to C-cadherin, AA5, that restores 
strong adhesion to activin-treated blastomeres. This
C-cadherin activating antibody strongly inhibits the 
elongation of animal caps in response to activin without 
affecting mesodermal gene expression. Thus, the ac-
tivin-induced decrease in C-cadherin adhesive activity 
appears to be required for animal cap elongation.
Regulation of C-cadherin and its activation by mAb 
AA5 involve changes in the state of C-cadherin that en-
compass more than changes in its homophilic binding 
site. Although mAb AA5 elicited a small enhancement 
in the functional activity of the soluble C-cadherin 
ectodomain (CEC1-5), it was not able to restore cell ad-
hesion activity to mutant C-cadherin lacking its cyto-
plasmic tail. Furthermore, activin treatment regulates 
the adhesion of 
 
Xenopus
 
 blastomeres to surfaces 
coated with two other antiÐC-cadherin mAbs, even 
though these antibodies probably do not mediate adhe-
sion through a normal homophilic binding mechanism. 
Moreover, mAb AA5 restores strong adhesion to these 
antibodies. mAb AA5 only activates adhesion of blas-
tomeres to immobilized CEC1-5 when it binds to
C-cadherin on the cell surface. It does not work when 
added to CEC1-5 on the substrate. Together these find-
ings suggest that the regulation of C-cadherin by activin 
and its activation by mAb AA5 involve changes in its 
cellular organization or interactions with other cell 
components that are not intrinsic to the isolated pro-
tein.
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T
 
HE
 
 regulation of cadherin-mediated adhesion is im-
portant for many morphogenetic processes (Gum-
biner, 1992, 1996). Most apparent is the loss or gain
of cadherin expression, which is thought to control the ex-
treme states of cell association in tissues (Takeichi, 1995;
Gumbiner, 1996). However, there is also evidence that
acute regulation of cadherin function at the cell surface is
important for tissue morphogenesis. Examples include E-cad-
herin regulation during mouse embryo compaction (Flem-
ing and Johnson, 1988), C-cadherin regulation during
 
Xenopus
 
 gastrulation (Brieher and Gumbiner, 1994; Lee
and Gumbiner, 1995), and N-cadherin regulation during
neurite outgrowth (Bixby and Zhang, 1990). Nevertheless,
the role of cadherin functional regulation in various mor-
phogenetic processes is still not well known, nor are the
mechanisms underlying cadherin regulation well under-
stood.
We have been studying the role of a 
 
Xenopus
 
 cadherin,
called C-cadherin, in the convergence and extension move-
ments that drive morphogenesis during amphibian gastru-
lation (Brieher and Gumbiner, 1994). C-cadherin is the
major cadherin expressed in the blastula and early gastrula
and is largely responsible for holding the cells of the early
embryo together (Heasman et al., 1994; Lee and Gum-
biner, 1995). Both the expression of dominant negative
forms of C-cadherin and the overexpression of wild-type 
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C-cadherin perturb gastrulation movements, suggesting
that appropriate levels of cell adhesion are required for
normal morphogenesis (Lee and Gumbiner, 1995).
The adhesive activity of C-cadherin at the cell surface is
decreased when animal cap tissue explants are induced by
the growth factor activin to undergo tissue elongation
(Brieher and Gumbiner, 1994) which results from conver-
gence extension movements (Symes and Smith, 1987). We
hypothesized that this regulation of C-cadherin activity is
important for the rearrangement of cells that underlies
elongation of the tissue. Although perturbation by the
dominant negative cadherins is consistent with this hy-
pothesis, a direct test requires that we manipulate the reg-
ulation of C-cadherin.
Little is known about the mechanisms underlying cad-
herin regulation. There is some evidence that phosphory-
lation cascades by the v-src and receptor tyrosine kinases
modulate cadherin-mediated adhesion (Behrens et al.,
1993). Tyrosine phosphorylation of 
 
b
 
-catenin has been ob-
served (Matsuyoshi et al., 1992; Hamaguchi et al., 1993),
but its physiological significance is uncertain (Takeda et al.,
1995). Small rho-family GTPases may also affect cadherin-
mediated adhesion (Hordijk et al., 1997; Takaishi et al.,
1997; Tokman et al., 1997). A recent study suggests that
IQGAP may alter cadherinÐcatenin interaction (Kuroda
et al., 1998), but alteration of the complex is not observed
in all cases of cadherin regulation (Behrens et al., 1993;
Brieher and Gumbiner, 1994). Even accepting that such
intracellular signal transduction events are causally linked
to regulation of cadherin-mediated adhesion, there is still
a need to understand how structural modifications or rear-
rangements of cadherins at the cell surface regulate the
state of cellÐcell adhesion. By comparison, integrins are
thought to be regulated either by affinity modulation or by
changes in lateral clustering (Schwartz et al., 1995; Stuiver
and OÕToole, 1995; Humphries, 1996).
One successful approach to the analysis of integrin regu-
lation has been the use of specific mAbs that either acti-
vate the high adhesive state or bind selectively to activated
integrins (Schwartz et al., 1995; Stuiver and OÕToole, 1995;
Humphries, 1996). Therefore, we decided to search for
C-cadherin activating antibodies and to use these antibodies
to investigate the mechanism of cadherin regulation and to
evaluate the role of C-cadherin regulation in the conver-
gence extensionÐlike elongation of the 
 
Xenopus
 
 animal cap.
 
Materials and Methods
 
Protein Purification and Production of mAbs
 
CEC1-5 protein was purified from conditioned media as reported previ-
ously (Brieher et al., 1996). Production of monoclonal antibodies was
based on methods previously described (Campbell, 1984). Briefly, BALB/c
mice were immunized five times subcutaneously with 50 
 
m
 
g of purified
CEC1-5 protein in the presence of adjuvant. 3 d before time of killing,
mice were injected intraperitoneally with 100 
 
m
 
g of CEC1-5 protein in the
absence of adjuvant. Spleens were removed and spleen cells were fused
with Sp2 myeloma cells, and the resultant hybrid cells were transferred to
96-well plates. The supernatants were first screened by ELISA or immu-
noblots for reactivity against CEC1-5 protein. Positive antiÐC-cadherin
producers were then screened for functional activity as described below.
 
Functional Screening Assay
 
To assay for C-cadherin binding activity on the blastomere surface, Fluo-
 
Spheres beads (Molecular Probes, Inc.) were coated with purified soluble
C-cadherin ectodomain, CEC1-5 (Brieher et al., 1996). FluoSpheres beads
were coated with CEC1-5 protein according to the manufacturerÕs instruc-
tions. Briefly, FluoSpheres were coupled with CEC1-5 at a ratio of 1 
 
m
 
g of
protein per 1 
 
m
 
l of beads in 20 mM Hepes, 100 mM NaCl, 1 mM CaCl
 
2
 
, pH
7.2, for 1 h, and then BSA and Tris were added to the medium at a final
concentration of 2 mg/ml and 20 mM (pH 7.2), respectively. After incuba-
tion for 1 h, the coated FluoSpheres were pelleted at 10,000 
 
g
 
 for 10 min
and then resuspended at 10 times their original volume in 20 mM Hepes,
100 mM NaCl, pH 7.2. The suspension was briefly sonicated to obtain sin-
gle particles as determined by fluorescence microscopy before the addi-
tion of 1 mM CaCl
 
2
 
.
 
Xenopus
 
 animal caps were excised from stage 8 embryos and dissoci-
ated to a single cell suspension by incubation in calcium- and magnesium-
free medium (CMFM) (Brieher and Gumbiner, 1994) for 2 h in a 35 mm
dish coated with 1% agarose in the same buffer.
The screening assay was performed at room temperature. The dissoci-
ated blastomeres were incubated with 5 ng/ml activin for 1 h and then in-
cubated with either the antiÐCEC1-5 monoclonal hybridoma supernatant
or RPMI medium (with 10% FCS) for 1 h. Calcium (final concentration 
 
5
 
2 mM) and CEC1-5Ðcoated FluoSpheres (20 
 
m
 
l for each experiment) were
added, and the mixture of blastomeres and FluoSpheres was agitated hor-
izontally for 30 min. Specimens were examined with a Zeiss Axioskop
equipped with plan-APOCHROMATx40 objective. Hybridoma superna-
tants were screened for the ability to stimulate the binding of CEC1-5 pro-
teinÐcoated FluoSpheres to activin-induced blastomeres (Fig. 1).
 
Cell Lines, mAbs, and Fab Fragments
 
CHO K1 cells, CEC1-5 expressing CHO cells, full-length C-cadherin ex-
pression CHO cells (C-CHO), and tailless truncated C-cadherin expres-
sion CHO cells (CT-CHO) were described previously (Brieher et al.,
1996; Yap et al., 1998).
To map the mAb AA5 binding epitope, cDNA encoding CEC1-5 and
CEC1-4, which lacks the fifth repeat, were transfected transiently in CHO
cells by lipofection as described previously (Brieher et al., 1996; Yap et al.,
1997b).
AntiÐC-cadherin mAbs (6B6 and 5G5) were described previously
(Brieher and Gumbiner, 1994). Large amounts of mAb AA5 were pro-
duced with a bioreactor by the mAb facility of Memorial Sloan-Kettering
Cancer Center. AA5, 6B6, and nonimmune mouse IgG were purified
from the supernatants using affinity chromatography on protein GÐSeph-
arose column. Fab fragments of AA5, 6B6, and nonimmune mouse IgG
were prepared using papain digestion and purification by protein AÐSeph-
arose as described previously (Campbell, 1984).
 
SDS-PAGE and Western Blots
 
Cells or blastomeres were extracted in 1% NP-40 extraction buffer (1%
NP-40, 10 mM Hepes, 150 mM NaCl, 1.5 mM EDTA, pH 7.4), supple-
mented with protease inhibitors as described previously (Choi and Gum-
biner, 1989). Volumes were adjusted to make all samples equal in protein
concentration by addition of SDS sample buffer, and proteins were sepa-
rated by SDS-PAGE. Proteins were transferred to nitrocellulose mem-
brane and probed with the mAbs AA5, 6B6, or nonimmune mouse IgG.
Immunolabeling was detected by the ECL detection system according to
the manufacturerÕs instructions (Amersham Corp.).
 
Embryos and Explants
 
Xenopus
 
 eggs and embryos were obtained by standard techniques (Kay
and Peng, 1991). All manipulations were at room temperature. Eggs were
squeezed into 1
 
3
 
 MMR (100 mM NaCl, 2 mM KCl, 2 mM CaCl
 
2
 
, 1 mM
MgCl
 
2
 
, and 5 mM Hepes, pH 7.4), and embryos were reared in 0.1
 
3
 
MMR. Embryos were dejellied in 2% cysteine HCl (pH 7.8Ð8.0). Staging
of embryos was according to Nieuwkoop and Faber (1967).
To analyze antibody effects on the elongation of activin-induced ani-
mal caps, 
 
Xenopus
 
 animal caps were isolated from stage 8 embryos and in-
cubated in 1
 
3
 
 MMR with or without activin (5 ng/ml) and either mAb
AA5 Fab (1 
 
m
 
g/ml) or mouse IgG Fab (1 
 
m
 
g/ml) overnight at 15
 
8
 
C. The
animal caps were analyzed by photographing and scoring for presence or
absence of elongation.
 
RNA Injection
 
To construct the IL-2
 
b
 
 receptorÐC-cadherin cytoplasmic tail fusion 
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cDNA, PCR was used to attach 5
 
9
 
 HindIII and 3
 
9
 
 XbaI sites on the cyto-
plasmic tail of C-cadherin. The PCR product was fused in frame to the
IL-2
 
b
 
 receptor using the HindIII and XbaI sites. The resulting fusion con-
struct was subcloned into pCS2 and transcribed in vitro with SP6 as de-
scribed (Funayama et al., 1995; Fagotto et al., 1997). 5 ng of mRNA was
injected into fertilized eggs at the one cell stage.
 
Analysis of RNA Expression by RT-PCR
 
For RT-PCR experiments, animal caps were removed from stage 8 em-
bryos and incubated in activin (5 ng/ml) with or without AA5 Fab (5 
 
m
 
g/ml)
overnight at 15
 
8
 
C. 15 caps were used for each experiment. Total RNA was
extracted using the Ultraspec RNA isolation system (Biotecx Laborato-
ries, Inc.). Various specific RNAs were detected by RT-PCR as described
previously (Fagotto et al., 1997). Primers were: for Goosecoid, 5
 
9
 
: ACA
ACT GGA AGC ACT GGA and 3
 
9
 
: TCA TAT TCC AGA GGA ACC;
for Brachyury, 5
 
9
 
: GGA TCG TTA TCA CCT CTG and 3
 
9
 
: GTG TAG
TCT GTA GCA GCA; for EF-1, 5
 
9
 
: CAG ATT GGT GCT FFA TAT
GC and 3
 
9
 
: AC TGC CTT GAT GAC TCC TAG.
 
Blastomere Adhesion Assays
 
For both aggregation assays and blastomere attachment assays, animal
caps of 
 
Xenopus
 
 were excised from stage 8 embryos and dissociated to sin-
gle cell suspensions in CMFM. Five animal caps were used for each exper-
iment. Dissociated blastomeres were incubated with 5 ng/ml activin for 60
min in agarose-coated dishes. Activin-induced blastomeres were trans-
ferred into 2% albuminÐcoated 1.5-ml centrifuge tube and incubated with
either AA5 Fab or nonimmune mouse IgG Fab for 30 min. For aggrega-
tion assays, treated blastomeres were moved back to the agarose-coated
dish, and subsequently aggregated at room temperature. Aggregation pro-
ceeded during a horizontal rocking in CMFM with 2 mM CaCl
 
2
 
 for 15
min. Cell aggregation was analyzed by photographing random fields from
each sample. For the attachment assays, substrates were prepared by spot-
ting 10 
 
m
 
l of either 1 
 
m
 
g/ml CEC1-5, 1 
 
m
 
g/ml fibronectin, or of 10 
 
m
 
g of rel-
evant mAb at a distance of 1 cm from the edge of 10-cm petri dishes.
AntiÐC-cadherin mAbs 6B6 and 5G5 have been described previously
(Brieher and Gumbiner, 1994). mAb BB 10 was used for the experiments
using the IL-2
 
b
 
 receptor. The entire dish was then blocked for 2 h with 10
mg/ml BSA in 1
 
3
 
 MMR. 25 
 
m
 
l of a suspension of dissociated blastomeres
(5 animal cap equivalents per ml) was spotted on the region of the dish
coated with the substrate. The blastomeres were allowed to attach for 30
min after which the dish was swirled and the number of blastomeres re-
maining was counted.
 
Laminar-Flow Adhesion Assay for CHO Cells
 
The modified laminar-flow assay was performed as described previously
(Brieher et al., 1996; Yap et al., 1997b, 1998). 1-mm internal diameter glass
capillary tubes were coated with 5 
 
m
 
g/ml CEC1-5 in the presence of cal-
cium for 8 h at 4
 
8
 
C. The capillary was subsequently blocked with 10 mg/ml
BSA for 2 h at room temperature. The coated capillary was connected to a
60-cm
 
3
 
 syringe attached to a syringe pump and mounted on an inverted
microscope.
Full-length C-cadherin expression CHO cells (C-CHO) or tailless trun-
cated C-cadherin expression CHO cells (CT-CHO) were harvested using
a procedure that leaves cadherins intact as described previously (Brieher
et al., 1996; Yap et al., 1998). The laminar-flow assay was performed at
room temperature. The concentration of cells was adjusted to 2 
 
3
 
 10
 
5
 
cells/ml and either AA5 Fab, 6B6 Fab, or nonimmune mouse IgG Fab (fi-
nal concentration at 1 
 
m
 
g/ml) was added to various cell suspensions. Cells
were drawn into the coated capillary from a reservoir using the pump. Af-
ter 1 min, the flow was stopped and the cells were allowed to bind to the
surface under static conditions for 10 or 30 min. Capillaries were observed
with a phase microscope and the number of cells in a 
 
3
 
20 field was then
counted. Flow was initiated and the number of cells remaining in the field
was counted after 30 s. Subsequently, the flow was doubled every 30 s, and
the number of cells remaining in the field was counted at the end of each
time point.
 
Bead Aggregation Assay
 
To perform the bead aggregation assay, FluoSpheres were coated with
CEC1-5 as described above. The coated FluoSpheres were sonicated to
obtain single particles as determined by fluorescence microscopy. The ag-
gregation assay was performed at room temperature. 20 
 
m
 
l of a suspension
 
of coated FluoSpheres was used for each experiment. The coated Fluo-
Spheres were transferred to an albumin-coated centrifuge tube and incu-
bated with 2 mM CaCl
 
2
 
, 20 mM NaCl, and AA5 Fab or nonimmune
mouse IgG Fab (final concentration at 1 
 
m
 
g/ml) for various time periods.
As a control, the CEC1-5 proteinÐcoated FluoSpheres were also incu-
bated with 2 mM EDTA instead of calcium for various time periods. Sam-
ples of FluoSpheres aggregates were aliquoted and suprathreshold sized
particle aggregates were counted using a Coulter counter.
 
Results
 
Identification of a C-cadherin Activating Antibody
 
The adhesive activity of C-cadherin on the surface of 
 
Xe-
nopus
 
 embryonic blastomeres is decreased in response
to activin treatment (Brieher and Gumbiner, 1994). We
therefore sought antiÐC-cadherin mAbs that would re-
store the state of C-cadherinÐmediated adhesion of ac-
tivin-treated blastomeres to the same level as untreated
blastomeres. To do so we modified an assay previously
used to measure C-cadherin regulation, which entailed the
binding of fluorescently labeled C-cadherin expressing
fibroblasts to the blastomeres (Brieher and Gumbiner,
1994). In the modified assay, we used fluorescent beads
coated with purified C-cadherin ectodomain (CEC1-5) as
the binding probe in place of the fibroblasts (Fig. 1 A).
Numerous CEC1-5Ðcoated beads bound to the surface of
untreated blastomeres (left), and treatment of blastomeres
with activin greatly reduced the number of beads bound
(center).
mAbs were raised to CEC1-5 and screened first for re-
activity to CEC1-5 by ELISA or Western blotting. The
positive hybridoma supernatants were then screened in
the functional assay described above for C-cadherin acti-
vating activity. Greater than 600 supernatants from 6
fusions were positive for reactivity with C-cadherin in
ELISA. Of these, only one exhibited clear reproducible
activating activity. This mAb, designated AA5, stimulated
the binding of CEC1-5Ðcoated beads to activin-treated
blastomeres (Fig. 1 A, right). mAb AA5 was therefore
subcloned and characterized further.
mAb AA5 binds to purified CEC1-5 in Western blots
(Fig. 1 B) and specifically recognizes C-cadherin expressed
in CHO cells (Fig. 1 C). We were also able to map the
AA5 binding epitope to the fifth extracellular cadherin re-
peat that is predicted to lie nearest to the membrane (Fig.
1 D). CEC1-5 and CEC1-4, which lacks the fifth repeat,
were expressed transiently in CHO cells and immunoblot-
ted with either mAb AA5 or another antiÐC-cadherin
mAb (6B6) described previously. Although mAb 6B6 rec-
ognizes both CEC1-5 and CEC1-4, mAb AA5 recognizes
only the full-length ectodomain.
Although mAb AA5 stimulates CEC1-5Ðcoated bead
binding to blastomeres, we wished to determine whether it
stimulated blastomere adhesion using more standard types
of adhesion assays. Furthermore, to rule out artifactual ad-
hesion due to crosslinking by the bivalent antibody, we
also tested monovalent Fab fragments of mAb AA5. Fab
fragments of mAb AA5 also stimulated CEC1-5Ðcoated
beads binding to blastomeres (data not shown). In all fur-
ther experiments described, purified Fab fragments of
mAb AA5 were used (although still referred to as mAb
AA5). Activin treatment reduces the rate of Ca
 
2
 
1
 
-depen- 
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dent aggregation of animal cap blastomeres that had been
dissociated by Ca
 
2
 
1
 
 removal (Brieher and Gumbiner,
1994) (Fig. 2 A, left and center). Inclusion of mAb AA5
in  the aggregation assay stimulated the rate of blasto-
mere aggregation of activin-treated blastomeres, produc-
ing larger aggregates after the same time interval (Fig. 2
A, right). We also examined the activity of mAb AA5 in a
cell attachment assay (Fig. 2 B). Attachment of dissociated
blastomeres to surfaces coated with CEC1-5 was assayed.
No attachment to BSA-coated surfaces was observed (data
not shown). Activin treatment reduced the number of
blastomeres that adhered to CEC1-5 under gentle shaking
conditions, and mAb AA5 significantly increased the num-
ber of activin-treated blastomeres that adhered to CEC1-5.
Thus, monovalent Fab fragments of mAb AA5 stimulated
C-cadherinÐmediated adhesion of activin-treated blasto-
meres to near the level of adhesion of untreated blas-
tomeres.
 
Inhibition of Activin-induced Morphogenetic 
Movements by mAb AA5
 
Activin induces 
 
Xenopus
 
 animal cap explants to elongate
as a result of convergent extension movements (Symes
and Smith, 1987; Brieher and Gumbiner, 1994) (Fig. 3).
We proposed that the activin-induced decrease in C-cad-
herinÐmediated adhesion is necessary for tissue elongation
(Brieher and Gumbiner, 1994). To test this hypothesis, we
asked whether mAb AA5, which maintains high levels of
C-cadherinÐmediated adhesion even after activin treat-
ment, would affect animal cap elongation (Fig. 3, A and
B). As described previously, activin induced 
 
z
 
95% of the
animal caps to elongate significantly, forming asymmetric
structures. In the absence of activin, all of the animal caps
form nearly spherical structures. mAb AA5 strongly inhib-
ited animal cap elongation in response to activin (Fig. 3 A,
far right). Only 
 
z
 
30% of the animal caps formed asym-
metric structures that could be scored as elongated (Fig. 3
B), and even these were relatively stunted compared to
the nonimmune IgG control. Although the majority of the
mAb AA5-treated caps did not elongate significantly, they
appeared ÒlumpierÓ than the smooth spherical structures
formed in the absence of activin, suggesting that mAb
Figure 1. Detection of antiÐC-cadherin activating mAb AA5 in a
functional screen. (A) mAb AA5 restores high C-cadherinÐmedi-
ated adhesion to activin-treated Xenopus blastomeres. Dissoci-
ated Xenopus animal cap blastomeres were treated with or with-
out activin (5 ng/ml). The activin-induced blastomeres were
treated with either mAb AA5 hybridoma supernatant or nonim-
mune mouse IgG. Blastomere samples were then incubated with
CEC1-5Ðcoated FluoSpheres in the presence of calcium for 60
min. (B, C, and D) Western blot analysis demonstrating mAb
AA5 binds to domain 5 of C-cadherin. CEC1-5 protein (B),
CEC1-5 expressing CHO cell extracts (C), and CEC1-4 express-
ing CHO cells extracts (D) were probed with antiÐC-cadherin
6B6 mAb, AA5 mAb, or nonimmune mouse IgG.
Figure 2. mAb AA5 enhances the C-cadherinÐmediated adhe-
sion of activin-induced animal cap blastomeres. (A) Blastomere
aggregation assay. Dissociated blastomeres were treated with or
without activin (5 ng/ml). Activin-treated blastomeres were incu-
bated either with mAb AA5 Fab (1 mg/ml) or nonimmune mouse
IgG Fab (1 mg/ml) in the presence of calcium, and then allowed
to aggregate with constant shaking for 15 min. (B) Blastomere
adhesion to CEC1-5. Dissociated blastomeres were treated with
or without activin. Activin-treated blastomeres were incubated
with either mAb AA5 Fab or nonimmune mouse IgG Fab, and
then allowed to attach to spots of CEC1-5 protein coated on a tis-
sue culture plate in the presence of calcium for 30 min. The plates
were then shaken continuously for 2 min on a horizontal shaker
and the numbers of blastomeres per unit area remaining attached
were counted. The graph shows the results of three different ex-
periments, each performed in duplicate. 
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AA5 did not completely block all morphogenetic move-
ment. A different mAb that inhibits C-cadherinÐmediated
adhesion, 6B6, did not block elongation to the same extent
as mAb AA5, even though it did affect the morphology of
the elongated caps. Thus, preventing the activin-induced
decrease in C-cadherinÐmediated adhesion significantly
 
inhibited the morphogenetic elongation of the tissue, indi-
cating that the change in C-cadherinÐmediated adhesion is
required for the process.
mAb AA5 could affect morphogenesis of the animal
caps in two ways; either directly by affecting the physical
adhesion between blastomeres in the tissue, or indirectly
by somehow inhibiting the whole process of mesoderm in-
duction by activin. The latter possibility was tested by de-
termining whether mAb AA5 inhibited the induction of
mesoderm specific genes using RT-PCR analysis (Fig. 3
C). Two mesodermal specific markers were analyzed.
Goosecoid is a marker for dorsal mesoderm, and its ex-
pression is associated with convergent extension morpho-
genesis (Smith et al., 1991). Brachyury is a marker for ven-
tralÐlateral mesoderm, and while its expression can be
induced by activin, it is often expressed in untreated ani-
mal caps when they are large and/or taken from later stage
blastulae (Cho et al., 1991). Similar to previous publica-
tions (Smith et al., 1991), we find that activin induces
goosecoid expression in animal caps, yet mAb AA5 did
not inhibit goosecoid induction. Also, mAb AA5 did not
inhibit the expression of brachyury, which, in this experi-
ment, was expressed even without activin treatment. Thus,
mAb AA5 does not inhibit general mesodermal gene ex-
pression in response to activin. Its effects on morphogene-
sis are more likely due to its direct effects on C-cadherinÐ
mediated adhesion.
 
Analysis of Mode of Action of mAb AA5
 
Experiments were undertaken to determine how mAb
AA5 activates C-cadherin. For integrins, there are two
general classes of activating mAbs. One class, exemplified
by anti-
 
b
 
3
 
 mAbs including P41 (OÕToole et al., 1990), Ab
62 (OÕToole et al., 1990), and D3GP3 (Kouns et al., 1990),
binds to and stabilizes a high-affinity conformation of the
isolated integrin protein. The second class is more com-
plex and requires cellular processes to activate the integrin
(Shattil et al., 1985; Dransfield and Hogg, 1990). To deter-
mine whether mAb AA5 influences the homophilic bind-
ing function of the purified CEC1-5 ectodomain, its effect
on the aggregation of CEC1-5Ðcoated beads was assayed.
Previous experiments showed that bead aggregation de-
pended on calcium and the dimerization of CEC1-5 and was
strongly inhibited by inhibitory antiÐC-cadherin mAbs
6B6 and 5G5 (Brieher et al., 1996). In contrast, mAb AA5
weakly, but reproducibly enhanced the rate of CEC1-
5Ðcoated bead aggregation (Fig. 4 C). This suggests that
mAb AA5 can affect to some extent the intrinsic ho-
mophilic binding function of the CEC1-5 ectodomain in-
dependent of cellular context.
To try to analyze the effect of mAb AA5 on C-cadherin
in a simple cellular context, its effect on the strength of
C-cadherinÐmediated adhesion when expressed in CHO
cells was assayed (Fig. 4). The strength of adhesion to pu-
rified CEC1-5 was measured by a laminar flow detach-
ment assay described previously (Brieher et al., 1996; Yap
et al., 1997a, 1998). mAb AA5 has no significant effect on
the strength of attachment of CHO cells expressing wild-
type C-cadherin (Fig. 4 A). This suggests that in the con-
text of CHO cells C-cadherin either exists in a completely
activated state (like blastomeres before treatment with
Figure 3. Inhibition of activin-induced morphogenetic move-
ment of animal cap explants by mAb AA5. (A) Inhibition of the
elongation of activin-induced animal caps by mAb AA5. Xeno-
pus animal caps were incubated with or without activin and
treated with mAb AA5 Fab (1 mg/ml), mAb 6B6 Fab (1 mg/ml),
or nonimmune mouse IgG Fab (1 mg/ml). (B) Frequency of inhi-
bition of elongation by mAb AA5. Activin-induced elongation
was plotted as a percentage of the total. n 5 total animal caps an-
alyzed. Any explant exhibiting a discernible protrusion was
scored as elongated. (C) mAb AA5 did not inhibit the induction
of expression of mesodermal gene markers in response to activin.
Animal caps were incubated with or without activin and incu-
bated either with mAb AA5 Fab (1 mg/ml) or nonimmune mouse
IgG Fab (1 mg/ml) until gastrula stage 10.5. Total RNA was har-
vested and mRNA was analyzed by RT-PCR for the presence of
the indicated transcripts. RNA from whole embryos (E) provides
a positive control. The 2RT lane is identical to the embryo lane,
except reverse transcriptase was omitted and serves as a negative
control. EF-1, ubiquitously expressed, is a loading control.
Brachyury is a marker of general mesoderm. Goosecoid is a
marker of dorsal mesoderm. 
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activin) or is somehow refractory to activation by
mAb AA5.
A mutant form of C-cadherin lacking its cytoplasmic tail
exhibits low levels of adhesion when expressed in CHO
cells (CT-CHO), reflecting its basic homophilic binding
activity (Brieher et al., 1996; Yap et al., 1998). We wished
to determine whether mAb AA5 could induce a change in
the C-cadherin ectodomain that is normally provided by
the cytoplasmic tail and associated cytoskeletal proteins.
mAb AA5 only weakly enhances the attachment strength
of CT-CHO cells (Fig. 4 B). This is consistent with the
bead aggregation assay and suggests that the mAb AA5
can affect to some extent the homophilic binding activity
of the protein in the absence of cytoplasmic interactions.
Note, however, that mAb AA5 was not able to restore full
cell adhesion activity to the tailless mutant C-cadherin
compared to wild-type C-cadherin, demonstrating that the
changes elicited by the antibody cannot substitute for the
normal cytoplasmic interactions of the cadherin.
Regulation of cell adhesion may involve complex changes
in the state of the adhesion molecule other than mod-
ulation of binding affinity. Therefore, we investigated
whether activin and mAb AA5 could regulate C-cad-
herinÐmediated adhesion independent of its homophilic
binding site. To do so, we assayed blastomere attachment
to two antiÐC-cadherin mAbs raised against portions of
C-cadherin expressed in bacteria, 6B6, and 5G5 (Brieher
and Gumbiner, 1994), which are not expected to interact
with C-cadherin via its homophilic binding site (Fig. 5).
 
Xenopus
 
 blastomeres do attach to surfaces coated with
these mAbs, and like attachment to CEC1-5, activin de-
creases the number of blastomeres that attach to the an-
tibodies (Fig. 5 A). This effect is specific to C-cadherin,
because activin did not decrease attachment to other sub-
strates. Activin did not affect the attachment of blasto-
meres to mAbs raised against another cell surface protein,
the IL-2
 
b
 
 receptor ectodomain fused to the C-cadherin cy-
toplasmic tail (Fig. 5 C). Moreover, as reported previously
(Smith et al., 1990), activin stimulates, instead of decreas-
ing, attachment of blastomeres to fibronectin (Fig. 5 B).
Therefore, activin specifically regulates the adhesion of
Figure 4. Analysis of mAb AA5 activity on cell lines and in vitro.
(A) Effect of mAb AA5 on C-cadherinÐmediated adhesion of
CHO cells. C-CHO cells (expressing wild-type C-cadherin) were
harvested in the presence of calcium and then allowed to attach
to CEC1-5Ðcoated capillary tube in the presence of either mAb
AA5 Fab or nonimmune mouse Fab for 30 min. Adhesive
strength was measured as the resistance of cell detachment to
progressively increasing flow rates. The experiment was per-
formed in triplicate and the percentage of cells remaining 6 SE
was plotted as a function of flow rate. (B) Effect of mAb AA5 on
the adhesive function of a cytoplasmic tail truncated C-cadherin
expressed in CHO cells (CT-CHO). Adhesion of CT-CHO cells
was assayed in the presence of either mAb AA5 Fab or nonim-
mune mouse Fab using the flow assay described in A. The effect of
inhibitory mAb 6B6 is shown for comparison. The experiment was
performed in triplicate and the percentage of cells remaining 6
SE was plotted as a function of time. (C) Effect of mAb AA5 on
the aggregation of CEC1-5Ðcoated FluoSpheres. Dispersed
CEC1-5Ðcoated FluoSpheres were incubated either with mAb
AA5 Fab or with nonimmune mouse IgG Fab in the presence of
calcium for various time periods. As a negative control, samples
were also incubated with the presence of EDTA. The number of
aggregated FluoSpheres (superthreshold particles) were counted
using a Coulter counter. The experiment was performed in tripli-
cate and the number of superthreshold particles 6 SE was plot-
ted as a function of time.
Figure 5. Activin regulation of blastomere attachment to antiÐ
C-cadherin mAbs. (A) Attachment of uninduced, activin-
induced, or activin-induced and mAb AA5-treated blastomeres
to substrates coated with CEC1-5, antiÐC-cadherin mAb 6B6, or
antiÐC-cadherin mAb 5G5. (B) Uninduced and activin-induced
blastomere attachment to fibronectin. (C) Attachment of unin-
duced and activin-induced blastomeres expressing an IL-2b re-
ceptorÐC-cadherin cytoplasmic tail fusion protein to substrates
coated with antiÐIL-2b receptor mAbs. 
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blastomeres to two different antiÐC-cadherin mAbs as
well as adhesion by the normal C-cadherin homophilic in-
teraction. Blastomere adhesion to mAbs 6B6 and 5G5 is
also activated by mAb AA5 (Fig. 5 A). Addition of mAb
AA5 stimulated the adhesion of activin-induced blas-
tomeres to the mAbs to the same extent as it stimulated
adhesion to CEC1-5, the homophilic binding substrate.
Since mAbs 6B6 and 5G5 are highly unlikely to interact
with C-cadherin through its homophilic binding site, these
findings provide evidence that regulation of C-cadherinÐ
mediated adhesion by activin and its activation by mAb
AA5 occur by mechanisms other than modulation of ho-
mophilic binding affinity.
These findings raise an important question about the
observations in Fig. 4, B and C. The intrinsic homophilic
binding properties of the cadherin ectodomain, CEC1-5,
are enhanced by mAb AA5. To what extent can the ef-
fects of mAb AA5 on the homophilic binding activity of
CEC1-5 account for the reversal of activin-induced regula-
tion of C-cadherin on the blastomere surface? To try to
address this question, we asked whether the activation
of blastomere adhesion by mAb AA5 occurs primarily
through direct effects on the purified CEC1-5 ectodomain
or through effects on the normal C-cadherin expressed on
the cell surface (Fig. 6). Blastomere adhesion to CEC1-5
provides C-cadherin in both contexts, purified ectodomain
on an inert surface and normal C-cadherin and its associ-
ated cytoplasmic proteins at the blastomere surface. mAb
AA5 was added either to the surface-bound CEC1-5 or to
the activin-treated blastomeres separately. mAb AA5 had
little or no effect when added to the surface-bound CEC1-5,
but exerted its full effect when added to the blastomeres.
This finding suggests that the enhanced homophilic bind-
ing activity of the cadherin ectodomain does not account
significantly for the activation of adhesion by mAb AA5.
Activation by mAb AA5 probably occurs primarily by al-
tering C-cadherin function in the context of the cell sur-
face.
 
Discussion
 
Activating mAbs have provided powerful tools to analyze
the regulation of integrin-mediated adhesion (Schwartz et al.,
1995; Stuiver and OÕToole, 1995; Humphries, 1996). Until
now, this approach had not been used for other types of
adhesion molecules. Since cadherins are thought to be reg-
ulated at the cell surface like the integrins, it seemed likely
that they would be good targets for a similar approach. We
have been able to generate such a cadherin-activating anti-
body by taking advantage of our ability to detect two ad-
hesive states of C-cadherin on the surface of 
 
Xenopus
 
blastomeres, a high adhesive state and a lower adhesive
state that is induced by treatment with the mesoderm-
inducing factor activin (Brieher and Gumbiner, 1994). The
mAb AA5 activates C-cadherin from the low to the higher
adhesive state, effectively reversing the response of C-cad-
herin to activin treatment.
mAb AA5 provided a tool to test the requirement for
C-cadherin regulation in the elongation of the 
 
Xenopus
 
animal cap. Previously our laboratory had established a
correlation between C-cadherin regulation and elongation
(Brieher and Gumbiner, 1994). It has been shown that in-
terference with normal C-cadherin function by overex-
pression or by dominant negative mutations perturbs mor-
phogenesis, but interpretation of these findings is limited
because of the requirement of C-cadherin in overall tissue
integrity (Heasman et al., 1994; Lee and Gumbiner, 1995).
What is needed instead is a selective inhibition of the ac-
tivin-induced regulation of adhesion in 
 
Xenopus
 
 blas-
tomeres. mAb AA5 achieves this selective inhibition,
since it blocks the response of C-cadherin to activin treat-
ment, but has no effect on C-cadherinÐmediated adhesion
in uninduced blastomeres, or in CHO cells expressing
wild-type C-cadherin. mAb AA5 strongly inhibits activin-
induced elongation of 
 
Xenopus
 
 animal caps without af-
fecting induction of mesoderm by activin. These findings
provide direct evidence that the downregulation in C-cad-
herin adhesive activity is required for the morphogenetic
movements underlying tissue elongation.
Different roles for C-cadherin regulation in tissue elon-
gation can be envisioned (Brieher and Gumbiner, 1994).
Elongation of tissues in the early 
 
Xenopus
 
 embryo is due
to convergence and extension, a morphogenetic process
that involves local cell rearrangements (Keller, 1987;
Gumbiner, 1992). To rearrange, cells must exchange
neighbors despite being held together by C-cadherin.
Downregulation of C-cadherin activity might play a pas-
sive role in morphogenesis, by simply allowing cells to
move relative to each other, with motility driven by an-
other mechanism. In this regard, it is interesting that the
activation state of integrin in the 
 
Xenopus
 
 embryo and
animal caps is also regulated by activin (Ramos and DeSi-
mone, 1996). Alternatively, a more active role for C-cad-
herin in these movements is also possible, similar to the
roles of integrins in the locomotion of individual cells on a
substratum. Convergent extension requires cell movement
on the surface of another cell (Keller, 1987; Gumbiner,
1992), and C-cadherin could act as the adhesive molecule
with which a moving cell generates traction. Indeed, cad-
herin-based cell motility seems plausible, because neurite
outgrowth can occur on purified N-cadherin (Bixby and
Zhang, 1990). In an active role, the global downregulation
of C-cadherin activity detected in these experiments may
reflect a more complex spatial and temporal regulation
Figure 6. mAb AA5 activates cell-associated C-cadherin only.
The ability of mAb AA5 to activate C-cadherin adhesion was de-
termined after its addition to different components of the cell at-
tachment assay. It was added either to the complete attachment
assay (as in Fig. 2), to the CEC1-5Ðcoated substrate alone
(rinsed), or to the blastomeres alone (rinsed). 
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needed to produce net movement, as is thought to occur
with integrins in locomoting cells (Lauffenburger and Hor-
witz, 1996).
We have begun to use mAb AA5 to try to elucidate the
molecular mechanisms underlying C-cadherin regulation.
Activating mAbs have been helpful in clarifying the mech-
anisms of integrin regulation, and provide valuable exam-
ples for comparison (Schwartz et al., 1995; Stuiver and
OÕToole, 1995; Humphries, 1996). There are two classes of
mAbs that activate the adhesive function of the platelet in-
tegrin, gpIIbIIIa (Stuiver and OÕToole, 1995; Humphries,
1996). One class acts by binding to and stabilizing the high-
affinity conformation of the isolated protein, directly en-
hancing its binding to its ligand, fibrinogen (Stuiver and
OÕToole, 1995; Humphries, 1996). Another class of mAbs
acts in a more complex and less understood manner by ac-
tivating adhesion only in the context of the cell, suggesting
a role for other plasma membranes or cytoplasmic compo-
nents (Stuiver and OÕToole, 1995; Humphries, 1996). For
C-cadherin and mAb AA5 it is more difficult to make the
distinction between these two modes of regulation, since
we do not have a method for measuring homophilic bind-
ing affinity. Nevertheless, knowledge about integrin-acti-
vating mAbs provides a conceptual framework for the
analysis of cadherin-activating mAbs.
C-cadherin downregulation by activin and activation by
mAb AA5 most likely occurs as a result of altering the
state of the protein in the cell membrane beyond simple
changes in the affinity of the homophilic binding site. Reg-
ulation of C-cadherin function by activin is apparent even
when blastomeres attach to two different antiÐC-cadherin
mAbs. mAb AA5 activates attachment of activin-induced
blastomeres to these antibodies, providing evidence that
this regulation occurs by a mechanism similar to the nor-
mal regulation of adhesion to C-cadherin. Because C-cad-
herin is unlikely to attach to these mAbs (6B6 and 5G5)
via its usual homophilic binding mechanism, another more
global property of C-cadherin is probably altered during
regulation. Examples of such a property include the state
of oligomerization or clustering of the cadherin, its attach-
ment to the actin cytoskeleton, or a global change in the
conformation of the protein (Gumbiner, 1996; Yap et al.,
1997a,b).
mAb AA5 is able to enhance somewhat the rate of bead
aggregation mediated by the soluble C-cadherin ectodo-
main (CEC1-5), suggesting that mAb AA5 causes changes
intrinsic to the protein. However, the effect of mAb AA5
on the isolated ectodomain does not seem to contribute
quantitatively to activation of blastomere adhesion. Using
an adhesion assay involving both the immobilized ecto-
domain and cell-associated C-cadherin, we found that
mAb AA5 could not activate adhesion when added to the
immobilized CEC1-5, but it was able to fully activate ad-
hesion when added to the cells alone. Therefore, mAb
AA5 is able to activate C-cadherin only when it is in a
cellular context and similar to the second class of integrin-
activating mAb. Since mAb AA5 must initiate its effects
through binding to the extracellular region, it may be pos-
sible to reconcile an intrinsic change in CEC1-5 with a re-
quirement for cellular context. For example, mAb AA5
could induce a conformational change in the extracellular
region that would both exert a very small effect on its ho-
 
mophilic binding activity (detectable with sufficient sensi-
tivity), and transduce a signal across the membrane to ef-
fect a change in cytoplasmic function or interactions.
There is evidence that the cadherin ectodomain can trans-
mit a signal across the membrane that influences its orga-
nization. C-cadherin clustering is ligand-dependent, occur-
ring only when cells specifically attach to C-cadherin (Yap
et al., 1997a). It is possible that mAb AA5 binding mimics
an initial homophilic binding event that leads to a change
in C-cadherin organization.
Determination of the molecular effect of mAb AA5 on
the C-cadherin adhesive complex would provide interest-
ing insights into the mechanism of cadherin regulation.
mAb AA5 binds to the fifth extracellular cadherin repeat
(EC5), which is adjacent to the membrane. This domain
differs somewhat in sequence from the other four cadherin
repeats in the classical cadherins, but its specific function is
not yet known (Takeichi, 1995; Gumbiner, 1996). Lateral
dimerization seems to be required for cadherin adhesive
function (Brieher et al., 1996), and it would be interesting
to know whether mAb AA5 binds preferentially to dimers
or induces dimerization. Despite several attempts, we
have been unable to detect any differences in binding to
monomeric or dimeric species of soluble CEC1-5, or any
changes in their relative distributions (our unpublished
observations). Also, we have not yet observed any changes
in the amounts of 
 
b
 
-catenin or 
 
a
 
-catenin interacting with
C-cadherin in 
 
Xenopus
 
 in response to activin treatment
(Brieher and Gumbiner, 1994). Changes in other protein
interactions, or more subtle or transient changes that we
have not yet been able to measure, may underlie reg-
ulation. Nonetheless, mAb AA5 provides us with an
additional tool that we can use to help understand the mol-
ecular mechanisms underlying the regulation of C-cad-
herinÐmediated adhesion by activin signaling.
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